Skip to content
Stock screener

AIFF Firefly Neuroscience, Inc. stock chart & analysis

Conviction 45TechnologyScan · Tue, Nov 10, 2026

Firefly Neuroscience, Inc. (AIFF) closed at $1.00 (+5.42%) on Nov 10, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 46, RS Rating 71, -68.3% from its 52-week high, +14.3% year to date. Sector: Technology · Services-Prepackaged Software.

AIFF$1.00+5.42%
ResistanceSupportVol 14
Loading chart…

Why AIFF moved

From the StockSetups movers recaps that covered AIFF, newest first. A recap states what was known that day.

Firefly Neuroscience, Inc.Services-Prepackaged Softwarewww.fireflyneuro.com ↗
Price1.00
Change+5.42%
Gap+2.36%
Rel volume0.41×
Avg volume92.56K
Avg $ vol92.36K
SMA 201.00
SMA 501.14
SMA 2001.37
Price vs 50-12.41%
Price vs 200-26.79%
MA stackbearish
50/200 cross—
Supertrenddown · 1.17
RSI (14)46
MACD hist0.00
MACD crossbull · 0d
Stoch %K / %D67 / 37
ADX (14)14
+DI / −DI20 / 24
RSI divergenceBullish
MACD divergenceBullish
ATR %8.90%
ADR %7.55%
52w high3.15
52w low0.6175
From 52w high-68.25%
Above 52w low+61.94%
New 52w highNo
SqueezeOn · 3d
Bollinger width21.05%
%B0.49
Donchian pos45.32%
Donchian high1.17
Donchian low0.8600
AVWAP (52w high)2.12
vs AVWAP high-52.80%
AVWAP (52w low)1.88
vs AVWAP low-46.69%
OBV trendFlat
Chaikin MF (20)-0.28
Today vs 20d0.41×
Avg vol (14d)92.75K
Avg vol (20d)92.56K
Avg $ vol (20d)92.36K
Market cap15.75M
RS Rating71 / 99
RS 3m (vs SPY)-6.99%
RS 6m (vs SPY)-46.03%
RS line new highNo
Trend template1/8
Technical rank23.1
1 week+2.04%
1 month-10.71%
3 months-9.91%
6 months-44.44%
1 year-38.65%
YTD+14.29%
P/E-0.79
P/B1.17
P/S13.79
P/FCF-1.92
EPS-1.97
Div yield—
ROE-148.06%
ROA-128.70%
Debt/Eq0.12
Current4.48
EV/EBITDA-1.08
Gross margin56.48%
Net margin—
Rev growth957.41%
EPS growth-90.08%
Price target—
Target upside—
Analyst rating—
Institutional9.99%
Ent. value9.39M
Revenue647K
Net income-1.48M
Gross profit525K
Free cash flow-8.19M
IndustryServices-Prepackaged Software
ExchangeNasdaq
Shares out15.57M
Employees17
ListedTue, Aug 13, 2024
Free float13.05M
Float %91.8%
Short interest—
Days to cover—
Short volume51.6%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction45 / 100
Pattern quality—
Tech rank23.1 / 100
Group rank14 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.69
Support0.9350
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

AIFF technical analysis

Trend

AIFF is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 12.4% below the 50-day ($1.14) and 26.8% below the 200-day ($1.37). ADX(14) at 14 points to a weak trend — more range than direction. It meets 1 of 8 trend-template criteria.

Momentum

RSI(14) is 46, in the bearish half of its range. MACD crossed above its signal line on the latest session. A bullish RSI divergence is in place. A bullish MACD divergence is in place. Its RS Rating of 71 puts its weighted 12-month performance ahead of about 71% of the US market.

Volume and volatility

Volume on the latest session ran 0.4× its 20-day average. It trades about $92,360 a day on average. ATR(14) is $0.0890, 8.9% of price — its typical daily range. Bollinger Bands are in a squeeze (3 sessions) — volatility is compressed. Chaikin Money Flow (-0.28) shows distribution.

Key levels

The chart pattern's support is $0.9350 and its resistance $1.69. The 52-week range is $0.6175 to $3.15; price is 68.3% below the high and 61.9% above the low. The VWAP anchored at the 52-week high is $2.12, above price.

Performance

AIFF returned +2.0% (1 week), -10.7% (1 month), -9.9% (3 months), -44.4% (6 months), -38.6% (1 year), +14.3% (year to date).

About Firefly Neuroscience, Inc.

Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.

Services-Prepackaged Software · Listed 2024 · 17 employees

Insider activity

SEC Form 4 transactions in AIFF

InsiderSideShares
Menawat Arun Swarup
Director · Deferred Stock Units · 2026-09-25
Grant126.05K
POSNER BRIAN M
Director · Deferred Stock Units · 2026-09-25
Grant84.03K
Vnook Stella
Director · Deferred Stock Units · 2026-09-25
Grant84.03K

SEC filings

EDGAR filings in AIFF · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.